Thanks to the Lung Health Cohort Research Study, the first large-scale lung health study, the American Lung Association strives toward achieving our mission to help transform lung health in the U.S.
Clinically significant reductions in bleeding underscore abelacimab’s strong potential to address an unmet need for patients with atrial fibrillation (AFib).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback